Literature DB >> 16831159

Risk factors for a poor outcome after therapy for acute pyelonephritis.

Peter E Pertel1, Daniel Haverstock.   

Abstract

OBJECTIVE: To define and characterize risk factors for the failure of treatment for acute uncomplicated pyelonephritis, as there are few reports available to predict which patients will respond poorly to treatment. PATIENTS AND METHODS: Retrospective univariate and multivariate logistic regression analyses were used to assess data from two prospective clinical trials designed to evaluate antibiotic regimens for urinary tract infections. Data from 522 adult patients with acute uncomplicated pyelonephritis were analysed.
RESULTS: The cure rate was 442/522 (85%) for patients with acute uncomplicated pyelonephritis. Significant independent predictors for treatment failure included hospitalization at baseline (P < 0.001), the presence of a resistant infecting organism (P < 0.001), diabetes mellitus (P = 0.001), and a history of kidney stones (P = 0.004). The cure rate was 35/74 (47%) for patients with at least one of these four risk factors. Of the 80 patients assessed as treatment failures, only 39 (49%) had at least one of the four risk factors.
CONCLUSION: Four risk factors for a poor outcome after therapy for acute uncomplicated pyelonephritis were identified. The strongest predictors of failure were the need for hospitalization at baseline and the presence of an organism resistant to the antimicrobial agent used for therapy. Two other factors, diabetes mellitus and a history of kidney stones, might assist clinicians at the initial evaluation to decide which patients are at risk of subsequent treatment failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831159     DOI: 10.1111/j.1464-410X.2006.06222.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

1.  Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women.

Authors:  U-Im Chang; Hyung Wook Kim; Seong-Heon Wie
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Urinary tract infection in diabetes: epidemiologic considerations.

Authors:  Victoire de Lastours; Betsy Foxman
Journal:  Curr Infect Dis Rep       Date:  2014-01       Impact factor: 3.725

3.  Retrospective Comparison of Clinical Characteristics and In-Hospital Outcomes among Diabetic and Non-Diabetic Adults with Acute Pyelonephritis.

Authors:  Shailesh C Trivedi; Sanjeev R Phatak; Renu S Trivedi
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 4.  Sporadic bilateral synchronous multicentric papillary renal cell carcinoma masquerading as bilateral multifocal pyelonephritis.

Authors:  V S Karthikeyan; L N Dorairajan; S Kumar; A R Vijayakumar; A Ramesh; N Ganesh Rajesh; D Halanaik; S Gupta
Journal:  Ann R Coll Surg Engl       Date:  2014-07       Impact factor: 1.891

5.  Risk factors for treatment failure in renal suppurative infections.

Authors:  Miroslav M Stojadinović; Sava R Mićić; Dragan R Milovanović; Slobodan M Janković
Journal:  Int Urol Nephrol       Date:  2008-08-15       Impact factor: 2.370

6.  Acute Pyelonephritis - Correlation of Clinical Parameter with Radiological Imaging Abnormalities.

Authors:  Leelavathi Venkatesh; Ramalingiah Karadakere Hanumegowda
Journal:  J Clin Diagn Res       Date:  2017-06-01

Review 7.  Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Walid Saliba
Journal:  Diabetes Metab Syndr Obes       Date:  2015-02-26       Impact factor: 3.168

8.  Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.

Authors:  Myra W Popejoy; Jianmin Long; Jennifer A Huntington
Journal:  BMC Infect Dis       Date:  2017-05-02       Impact factor: 3.090

9.  Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection.

Authors:  Vasilios Kalas; Michael E Hibbing; Amarendar Reddy Maddirala; Ryan Chugani; Jerome S Pinkner; Laurel K Mydock-McGrane; Matt S Conover; James W Janetka; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

10.  Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study.

Authors:  Veronica A Buonaiuto; Ignacio Marquez; Inmaculada De Toro; Carolina Joya; Juan D Ruiz-Mesa; Raimundo Seara; Antonio Plata; Beatriz Sobrino; Begoña Palop; Juan D Colmenero
Journal:  BMC Infect Dis       Date:  2014-12-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.